1. Nintedanib plus mFOLFOX6 as second‐line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo‐controlled, phase II TRICC‐C study (AIO‐KRK‐0111). Issue 6 (4th October 2020) Authors: Ettrich, Thomas J.; Perkhofer, Lukas; Decker, Thomas; Hofheinz, Ralf‐Dieter; Heinemann, Volker; Hoffmann, Thomas; Hebart, Holger F.; Herrmann, Thomas; Hannig, Carla V.; Büchner‐Steudel, Petra; Güthle, Melanie; Hermann, Patrick C.; Berger, Andreas W.; Seufferlein, Thomas Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nintedanib plus mFOLFOX6 as second‐line treatment of metastatic, chemorefractory colorectal cancer: The randomised, placebo‐controlled, phase II TRICC‐C study (AIO‐KRK‐0111). Issue 6 (4th October 2020) Authors: Ettrich, Thomas J.; Perkhofer, Lukas; Decker, Thomas; Hofheinz, Ralf‐Dieter; Heinemann, Volker; Hoffmann, Thomas; Hebart, Holger F.; Herrmann, Thomas; Hannig, Carla V.; Büchner‐Steudel, Petra; Güthle, Melanie; Hermann, Patrick C.; Berger, Andreas W.; Seufferlein, Thomas Journal: International journal of cancer Issue: Volume 148:Issue 6(2021) Page Start: 1428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗